Cevaprost
Active substance
ATC code
Species
Cattle
Indications
Cattle
- Silent heat
- Ovarian luteal cysts
- Termination of pregnancy
- Induction of parturition
- Removal of mummified foetus
- Chronic endometritis (pyometra)
- Synchronisation of oestrus (within 2 to 5 days) in groups of cyclic females treated simultaneously
Dose to be administered and administration route
Single or repeated 2ml doses (equivalent to 500 mcg of cloprostenol) by intramuscular injection).
Therapeutic indications:
A) Silent heatThis condition is particularly common in heavy producing dairy cows, which have normal ovarian cycles but slightly express or do not express behavioural manifestations. These animals can be treated only after checking the cycle activity and the presence of the corpus luteum. Animals treated with the product may be bred (natural service or artificial insemination) 72 and 96 hours after treatment.
If the animal has been treated in the absence of a corpus luteum, another injection of the product is required 11 days after the first injection.
B) Ovarian luteal cystsThe product has demonstrated its efficacy in restoring normal the oestrus cycle in case of absence of heat caused by ovarian cysts (characterized by the presence of persistent luteal tissue).
C) Termination of pregnancyThe condition may occur in case of immature calves.
The pregnancy can be interrupted starting from one week after its establishment until day 150 of pregnancy. Before day 100, abortion can be induced quickly and effectively while between day 100 and day 150, results may be less significant because some cows may become progressively less sensitive to the action of corpus luteum maintaining pregnancy. The animals must be kept under observation until foetus and placental membranes complete expulsion.
D) Induction of parturitionFrom day 270 of pregnancy, the administration of the product induces parturition 30 – 60 hours of treatment. The induction of parturition should take place as close as possible to the expected date of spontaneous parturition. The induction of parturition should not be induced before day 270 day of pregnancy. All treated animals must be kept under observation. As with all other methods of shortening the pregnancy period, placental retention rate may be increased.
E) Removal of mummified foetusFoetus death may be followed by dehydration and degeneration. The induction of luteolysis at any stage of pregnancy causes the expulsion of mummified foetuses from the uterus to the vagina, from which it is possible to make manual removal. Usually, normal cyclic activity follows.
F) Chronic Endometritis (Pyometra)Reproduction system lesions caused during parturition or placental retention may cause uterine inflammation and infections known as endometritis. Acute or sub-acute endometritis, which may occur shortly after parturition, may require both local and general antibiotic treatments. This condition is known as pyometra and is characterised by the absence of annual cyclic activity and the presence of a persistent corpus luteum. The condition can be successfully treated by inducing the regression of the corpus luteum. If necessary, the treatment may be repeated after 10-14 days.
Controlled breeding:
A treatment consisting of two injections of the product at 11 days interval is highly effective for oestrus synchronization in healthy cycling cows. Two artificial inseminations at 72 and 96 hours after the second injection, involve a normal fertility rate. For economic reasons, if only one insemination is performed, this must be done after 72-84 hours but this may involve fewer pregnancies. Of cause, such protocol can vary. For example, it is possible to inseminate all animals in heat after the first injection and limit the second treatment, to the cows in which the first had no effect.
Adverse reactions
In very rare cases, anaphylactic-type reactions can be observed which require immediate medical care. Anaerobic infection may occur if anaerobic bacteria penetrate the tissue of the injection site. Typical local reactions due to anaerobic infection are swelling and crepitus at the injection site. When used for the induction of parturition and dependent on the time of treatment relative to the date of conception, the incidence of retained placenta may be increased.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 15052/4159 |
EAN | 3411113145002 |